世界のヘモグロビン症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hemoglobinopathies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4297 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ヘモグロビン症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（輸血、鉄キレート療法、骨髄移植、その他）、用途別市場規模（血液検査、遺伝子検査、着床前診断（PGD）、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ヘモグロビン症の市場動向 ・企業の競争状況、市場シェア ・ヘモグロビン症の種類別市場規模と予測2016-2027（輸血、鉄キレート療法、骨髄移植、その他） ・ヘモグロビン症の用途別市場規模と予測2016-2027（血液検査、遺伝子検査、着床前診断（PGD）、その他） ・ヘモグロビン症の北米市場規模2016-2027（アメリカ、カナダ） ・ヘモグロビン症の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヘモグロビン症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヘモグロビン症の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヘモグロビン症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Gamida Cell、Alnylam Pharmaceuticals、Sanofi、Sangamo Therapeutics Inc.、Global Blood Therapeutics、Bluebird Bio、Emmaus Life Sciences Inc.、Prolong Pharmaceuticals、Celgene Corporation） ・結論

Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.
Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers.

Market Analysis and Insights: Global Hemoglobinopathies Market
The global Hemoglobinopathies market size is projected to reach US$ 384.7 million by 2027, from US$ 274.5 million in 2020, at a CAGR of 4.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemoglobinopathies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemoglobinopathies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemoglobinopathies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemoglobinopathies market.

Global Hemoglobinopathies Scope and Market Size
Hemoglobinopathies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemoglobinopathies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Transfusion
Iron Chelation Therapy
Bone Marrow Transplant
Others

Segment by Application
Blood Testing
Genetic Testing
Pre-Implantation Genetic Diagnosis (PGD)
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gamida Cell
Alnylam Pharmaceuticals
Sanofi
Sangamo Therapeutics Inc.
Global Blood Therapeutics
Bluebird Bio
Emmaus Life Sciences Inc.
Prolong Pharmaceuticals
Celgene Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Transfusion
1.2.3 Iron Chelation Therapy
1.2.4 Bone Marrow Transplant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Hemoglobinopathies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Blood Testing
1.3.3 Genetic Testing
1.3.4 Pre-Implantation Genetic Diagnosis (PGD)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hemoglobinopathies Market Perspective (2016-2027)
2.2 Hemoglobinopathies Growth Trends by Regions
2.2.1 Hemoglobinopathies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemoglobinopathies Historic Market Share by Regions (2016-2021)
2.2.3 Hemoglobinopathies Forecasted Market Size by Regions (2022-2027)
2.3 Hemoglobinopathies Industry Dynamic
2.3.1 Hemoglobinopathies Market Trends
2.3.2 Hemoglobinopathies Market Drivers
2.3.3 Hemoglobinopathies Market Challenges
2.3.4 Hemoglobinopathies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathies Players by Revenue
3.1.1 Global Top Hemoglobinopathies Players by Revenue (2016-2021)
3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2016-2021)
3.2 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemoglobinopathies Revenue
3.4 Global Hemoglobinopathies Market Concentration Ratio
3.4.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2020
3.5 Hemoglobinopathies Key Players Head office and Area Served
3.6 Key Players Hemoglobinopathies Product Solution and Service
3.7 Date of Enter into Hemoglobinopathies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hemoglobinopathies Breakdown Data by Type
4.1 Global Hemoglobinopathies Historic Market Size by Type (2016-2021)
4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2022-2027)

5 Hemoglobinopathies Breakdown Data by Application
5.1 Global Hemoglobinopathies Historic Market Size by Application (2016-2021)
5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hemoglobinopathies Market Size (2016-2027)
6.2 North America Hemoglobinopathies Market Size by Type
6.2.1 North America Hemoglobinopathies Market Size by Type (2016-2021)
6.2.2 North America Hemoglobinopathies Market Size by Type (2022-2027)
6.2.3 North America Hemoglobinopathies Market Size by Type (2016-2027)
6.3 North America Hemoglobinopathies Market Size by Application
6.3.1 North America Hemoglobinopathies Market Size by Application (2016-2021)
6.3.2 North America Hemoglobinopathies Market Size by Application (2022-2027)
6.3.3 North America Hemoglobinopathies Market Size by Application (2016-2027)
6.4 North America Hemoglobinopathies Market Size by Country
6.4.1 North America Hemoglobinopathies Market Size by Country (2016-2021)
6.4.2 North America Hemoglobinopathies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hemoglobinopathies Market Size (2016-2027)
7.2 Europe Hemoglobinopathies Market Size by Type
7.2.1 Europe Hemoglobinopathies Market Size by Type (2016-2021)
7.2.2 Europe Hemoglobinopathies Market Size by Type (2022-2027)
7.2.3 Europe Hemoglobinopathies Market Size by Type (2016-2027)
7.3 Europe Hemoglobinopathies Market Size by Application
7.3.1 Europe Hemoglobinopathies Market Size by Application (2016-2021)
7.3.2 Europe Hemoglobinopathies Market Size by Application (2022-2027)
7.3.3 Europe Hemoglobinopathies Market Size by Application (2016-2027)
7.4 Europe Hemoglobinopathies Market Size by Country
7.4.1 Europe Hemoglobinopathies Market Size by Country (2016-2021)
7.4.2 Europe Hemoglobinopathies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hemoglobinopathies Market Size (2016-2027)
8.2 Asia-Pacific Hemoglobinopathies Market Size by Type
8.2.1 Asia-Pacific Hemoglobinopathies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemoglobinopathies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemoglobinopathies Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemoglobinopathies Market Size by Application
8.3.1 Asia-Pacific Hemoglobinopathies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemoglobinopathies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemoglobinopathies Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemoglobinopathies Market Size by Region
8.4.1 Asia-Pacific Hemoglobinopathies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemoglobinopathies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hemoglobinopathies Market Size (2016-2027)
9.2 Latin America Hemoglobinopathies Market Size by Type
9.2.1 Latin America Hemoglobinopathies Market Size by Type (2016-2021)
9.2.2 Latin America Hemoglobinopathies Market Size by Type (2022-2027)
9.2.3 Latin America Hemoglobinopathies Market Size by Type (2016-2027)
9.3 Latin America Hemoglobinopathies Market Size by Application
9.3.1 Latin America Hemoglobinopathies Market Size by Application (2016-2021)
9.3.2 Latin America Hemoglobinopathies Market Size by Application (2022-2027)
9.3.3 Latin America Hemoglobinopathies Market Size by Application (2016-2027)
9.4 Latin America Hemoglobinopathies Market Size by Country
9.4.1 Latin America Hemoglobinopathies Market Size by Country (2016-2021)
9.4.2 Latin America Hemoglobinopathies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hemoglobinopathies Market Size (2016-2027)
10.2 Middle East & Africa Hemoglobinopathies Market Size by Type
10.2.1 Middle East & Africa Hemoglobinopathies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemoglobinopathies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemoglobinopathies Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemoglobinopathies Market Size by Application
10.3.1 Middle East & Africa Hemoglobinopathies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemoglobinopathies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemoglobinopathies Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemoglobinopathies Market Size by Country
10.4.1 Middle East & Africa Hemoglobinopathies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemoglobinopathies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gamida Cell
11.1.1 Gamida Cell Company Details
11.1.2 Gamida Cell Business Overview
11.1.3 Gamida Cell Hemoglobinopathies Introduction
11.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2016-2021)
11.1.5 Gamida Cell Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Hemoglobinopathies Introduction
11.3.4 Sanofi Revenue in Hemoglobinopathies Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Sangamo Therapeutics Inc.
11.4.1 Sangamo Therapeutics Inc. Company Details
11.4.2 Sangamo Therapeutics Inc. Business Overview
11.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction
11.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2016-2021)
11.4.5 Sangamo Therapeutics Inc. Recent Development
11.5 Global Blood Therapeutics
11.5.1 Global Blood Therapeutics Company Details
11.5.2 Global Blood Therapeutics Business Overview
11.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction
11.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2016-2021)
11.5.5 Global Blood Therapeutics Recent Development
11.6 Bluebird Bio
11.6.1 Bluebird Bio Company Details
11.6.2 Bluebird Bio Business Overview
11.6.3 Bluebird Bio Hemoglobinopathies Introduction
11.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2016-2021)
11.6.5 Bluebird Bio Recent Development
11.7 Emmaus Life Sciences Inc.
11.7.1 Emmaus Life Sciences Inc. Company Details
11.7.2 Emmaus Life Sciences Inc. Business Overview
11.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction
11.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2016-2021)
11.7.5 Emmaus Life Sciences Inc. Recent Development
11.8 Prolong Pharmaceuticals
11.8.1 Prolong Pharmaceuticals Company Details
11.8.2 Prolong Pharmaceuticals Business Overview
11.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction
11.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021)
11.8.5 Prolong Pharmaceuticals Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Hemoglobinopathies Introduction
11.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2016-2021)
11.9.5 Celgene Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hemoglobinopathies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Iron Chelation Therapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Key Players of Others
Table 6. Global Hemoglobinopathies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hemoglobinopathies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hemoglobinopathies Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Hemoglobinopathies Market Share by Regions (2016-2021)
Table 10. Global Hemoglobinopathies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Hemoglobinopathies Market Share by Regions (2022-2027)
Table 12. Hemoglobinopathies Market Trends
Table 13. Hemoglobinopathies Market Drivers
Table 14. Hemoglobinopathies Market Challenges
Table 15. Hemoglobinopathies Market Restraints
Table 16. Global Hemoglobinopathies Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Hemoglobinopathies Market Share by Players (2016-2021)
Table 18. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2020)
Table 19. Ranking of Global Top Hemoglobinopathies Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Hemoglobinopathies Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemoglobinopathies Product Solution and Service
Table 23. Date of Enter into Hemoglobinopathies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Hemoglobinopathies Revenue Market Share by Type (2016-2021)
Table 27. Global Hemoglobinopathies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Hemoglobinopathies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Hemoglobinopathies Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Hemoglobinopathies Revenue Market Share by Application (2016-2021)
Table 31. Global Hemoglobinopathies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Hemoglobinopathies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hemoglobinopathies Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Hemoglobinopathies Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million)
Table 63. Gamida Cell Company Details
Table 64. Gamida Cell Business Overview
Table 65. Gamida Cell Hemoglobinopathies Product
Table 66. Gamida Cell Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 67. Gamida Cell Recent Development
Table 68. Alnylam Pharmaceuticals Company Details
Table 69. Alnylam Pharmaceuticals Business Overview
Table 70. Alnylam Pharmaceuticals Hemoglobinopathies Product
Table 71. Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 72. Alnylam Pharmaceuticals Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Hemoglobinopathies Product
Table 76. Sanofi Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Sangamo Therapeutics Inc. Company Details
Table 79. Sangamo Therapeutics Inc. Business Overview
Table 80. Sangamo Therapeutics Inc. Hemoglobinopathies Product
Table 81. Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 82. Sangamo Therapeutics Inc. Recent Development
Table 83. Global Blood Therapeutics Company Details
Table 84. Global Blood Therapeutics Business Overview
Table 85. Global Blood Therapeutics Hemoglobinopathies Product
Table 86. Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 87. Global Blood Therapeutics Recent Development
Table 88. Bluebird Bio Company Details
Table 89. Bluebird Bio Business Overview
Table 90. Bluebird Bio Hemoglobinopathies Product
Table 91. Bluebird Bio Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 92. Bluebird Bio Recent Development
Table 93. Emmaus Life Sciences Inc. Company Details
Table 94. Emmaus Life Sciences Inc. Business Overview
Table 95. Emmaus Life Sciences Inc. Hemoglobinopathies Product
Table 96. Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 97. Emmaus Life Sciences Inc. Recent Development
Table 98. Prolong Pharmaceuticals Company Details
Table 99. Prolong Pharmaceuticals Business Overview
Table 100. Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 101. Prolong Pharmaceuticals Recent Development
Table 102. Celgene Corporation Company Details
Table 103. Celgene Corporation Business Overview
Table 104. Celgene Corporation Hemoglobinopathies Product
Table 105. Celgene Corporation Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million)
Table 106. Celgene Corporation Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathies Market Share by Type: 2020 VS 2027
Figure 2. Blood Transfusion Features
Figure 3. Iron Chelation Therapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Others Features
Figure 6. Global Hemoglobinopathies Market Share by Application: 2020 VS 2027
Figure 7. Blood Testing Case Studies
Figure 8. Genetic Testing Case Studies
Figure 9. Pre-Implantation Genetic Diagnosis (PGD) Case Studies
Figure 10. Others Case Studies
Figure 11. Hemoglobinopathies Report Years Considered
Figure 12. Global Hemoglobinopathies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Hemoglobinopathies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hemoglobinopathies Market Share by Regions: 2020 VS 2027
Figure 15. Global Hemoglobinopathies Market Share by Regions (2022-2027)
Figure 16. Global Hemoglobinopathies Market Share by Players in 2020
Figure 17. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Hemoglobinopathies Revenue in 2020
Figure 19. Global Hemoglobinopathies Revenue Market Share by Type (2016-2021)
Figure 20. Global Hemoglobinopathies Revenue Market Share by Type (2022-2027)
Figure 21. North America Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Hemoglobinopathies Market Share by Type (2016-2027)
Figure 23. North America Hemoglobinopathies Market Share by Application (2016-2027)
Figure 24. North America Hemoglobinopathies Market Share by Country (2016-2027)
Figure 25. United States Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hemoglobinopathies Market Share by Type (2016-2027)
Figure 29. Europe Hemoglobinopathies Market Share by Application (2016-2027)
Figure 30. Europe Hemoglobinopathies Market Share by Country (2016-2027)
Figure 31. Germany Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hemoglobinopathies Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Hemoglobinopathies Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Hemoglobinopathies Market Share by Region (2016-2027)
Figure 41. China Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hemoglobinopathies Market Share by Type (2016-2027)
Figure 49. Latin America Hemoglobinopathies Market Share by Application (2016-2027)
Figure 50. Latin America Hemoglobinopathies Market Share by Country (2016-2027)
Figure 51. Mexico Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hemoglobinopathies Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Hemoglobinopathies Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Hemoglobinopathies Market Share by Country (2016-2027)
Figure 57. Turkey Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 63. Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 64. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 65. Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 66. Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 67. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 68. Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---